Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab for rhinovirus-induced asthma exacerbations
2011-000586-12Phase 2Active
- Sponsor
- Academic Medical Center
- Start
- Apr 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of mepolizumab in asthma, sponsored by Academic Medical Center. Started Apr 2011; status: active.
02
Drugs
mepolizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-000586-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000586-12.